Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818932 · ClinicalTrials.gov registry record · Phase 2
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
A Phase 2 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT03818932 is a Phase 2 study that has completed, run by Henry Ford Health System. The registered enrollment target is 90 participants.
The verdict
NCT03818932, a Phase 2 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of anterior cruciate ligament reconstruction: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen
Interventions
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Celecoxib
- DRUG Gabapentin
- DRUG Hydrocodone-Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2020-05-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03818932
The ClinicalTrials.gov registry entry for NCT03818932 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT03818932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03818932 about?
NCT03818932 is a clinical study titled "Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction". This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of anterior cruciate ligament reconstruction: a treatment group given a nonopioid pain control regimen, and a standard of care c...
What is the current status of trial NCT03818932?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2019-01-22. Estimated completion is 2020-05-20.
What interventions are being tested in trial NCT03818932?
The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Celecoxib (DRUG), Gabapentin (DRUG), Hydrocodone-Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT03818932?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.